ES2124995T3 - Epoxidos esteroides para el tratamiento del cancer. - Google Patents
Epoxidos esteroides para el tratamiento del cancer.Info
- Publication number
- ES2124995T3 ES2124995T3 ES95902957T ES95902957T ES2124995T3 ES 2124995 T3 ES2124995 T3 ES 2124995T3 ES 95902957 T ES95902957 T ES 95902957T ES 95902957 T ES95902957 T ES 95902957T ES 2124995 T3 ES2124995 T3 ES 2124995T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- atoms
- carbon
- alcoxide
- hydroxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- -1 STEROID EPOXIDES Chemical class 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 6
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 4
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 150000003431 steroids Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE SUMINISTRAN NUEVOS DERIVADOS ESTEROIDES QUE TIENEN ACCION ANTITUMORAL QUE PUEDEN SINTETIZARSE EFICIENTEMENTE Y ESTEREOSELECTIVAMENTE POR MEDIO DE QUIMICA ORGANICA SINTETICA. SE PRESENTA UN DERIVADO ESTEROIDE REPRESENTADO POR LA FORMULA (I) EN LA QUE R ES UN GRUPO DE ALQUILO DE ENTRE 1 Y 13 ATOMOS DE CARBONO, A ES UN GRUPO DE HIDROXILO O UN GRUPO FACILMENTE HIDROLIZABLE EN UN GRUPO DE HIDROXILO, X E Y FORMAN JUNTAS UN GRUPO DE OXO O UN GRUPO DE ALQUILENODIOXIDO QUE TIENE ENTRE 2 Y 3 ATOMOS DE CARBONO, X ES UN GRUPO DE HIDROXILO, UN GRUPO DE ALCOXIDO QUE TIENE ENTRE 1 Y 5 ATOMOS DE CARBONO O UN GRUPO FACILMENTE HIDROLIZABLE EN UN GRUPO DE HIDROXILO, Y ES UN ATOMO DE HIDROGENO O UN GRUPO DE ALCOXIDO QUE TIENE ENTRE 1 Y 5 ATOMOS DE CARBONO, CON LA CONDICION DE QUE CUANDO X SEA UN GRUPO DE HIDROXILO O UN GRUPO FACILMENTE HIDROLIZABLE EN UN GRUPO DE HIDROXILO, Y ES UN ATOMO DE HIDROGENO, Y CUANDO X SEA UN GRUPO DE ALCOXIDO QUE TENGA ENTRE 1 Y 5 ATOMOS DE CARBONO, Y ES UN GRUPO DE ALCOXIDO QUETIENE ENTRE 1 Y 5 ATOMOS DE CARBONO. TAMBIEN SE PRESENTA UNA SAL DEL DERIVADO.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31524693 | 1993-12-15 | ||
| PCT/JP1994/002102 WO1995016699A1 (fr) | 1993-12-15 | 1994-12-14 | Derive de steroide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2124995T3 true ES2124995T3 (es) | 1999-02-16 |
Family
ID=18063133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95902957T Expired - Lifetime ES2124995T3 (es) | 1993-12-15 | 1994-12-14 | Epoxidos esteroides para el tratamiento del cancer. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5712263A (es) |
| EP (1) | EP0735047B1 (es) |
| AT (1) | ATE173271T1 (es) |
| AU (1) | AU679302B2 (es) |
| CA (1) | CA2178900A1 (es) |
| DE (1) | DE69414602T2 (es) |
| DK (1) | DK0735047T3 (es) |
| ES (1) | ES2124995T3 (es) |
| WO (1) | WO1995016699A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1079859B1 (en) | 1998-05-22 | 2010-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息*** |
| EP1945240B1 (en) | 2005-09-16 | 2016-12-28 | Raptor Pharmaceutical Inc | Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof |
| PL3395372T3 (pl) | 2009-02-20 | 2022-07-25 | EnhanX Biopharm Inc. | Układ do dostarczania leków na bazie glutationu |
| KR20190116576A (ko) | 2009-05-06 | 2019-10-14 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5122521A (en) * | 1990-07-17 | 1992-06-16 | Taisho Pharmaceutical Co., Ltd. | Sterol compound |
-
1994
- 1994-12-14 ES ES95902957T patent/ES2124995T3/es not_active Expired - Lifetime
- 1994-12-14 WO PCT/JP1994/002102 patent/WO1995016699A1/ja active IP Right Grant
- 1994-12-14 EP EP95902957A patent/EP0735047B1/en not_active Expired - Lifetime
- 1994-12-14 AU AU12003/95A patent/AU679302B2/en not_active Ceased
- 1994-12-14 DK DK95902957T patent/DK0735047T3/da active
- 1994-12-14 AT AT95902957T patent/ATE173271T1/de not_active IP Right Cessation
- 1994-12-14 CA CA002178900A patent/CA2178900A1/en not_active Abandoned
- 1994-12-14 DE DE69414602T patent/DE69414602T2/de not_active Expired - Fee Related
-
1996
- 1996-06-14 US US08/663,929 patent/US5712263A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK0735047T3 (da) | 1999-07-26 |
| EP0735047B1 (en) | 1998-11-11 |
| AU1200395A (en) | 1995-07-03 |
| DE69414602T2 (de) | 1999-04-08 |
| ATE173271T1 (de) | 1998-11-15 |
| DE69414602D1 (de) | 1998-12-17 |
| EP0735047A1 (en) | 1996-10-02 |
| WO1995016699A1 (fr) | 1995-06-22 |
| CA2178900A1 (en) | 1995-06-22 |
| EP0735047A4 (en) | 1996-11-27 |
| US5712263A (en) | 1998-01-27 |
| AU679302B2 (en) | 1997-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2092589T3 (es) | Cierre para recipiente con un cuerpo de cierre perforable. | |
| ES2124995T3 (es) | Epoxidos esteroides para el tratamiento del cancer. | |
| ES2191963T3 (es) | Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos. | |
| ES2142642T3 (es) | Dispersiones de poliuretano acuosas latentemente reticulantes. | |
| ES2086144T3 (es) | Catalizador para la hidrolisis de sulfuro de carbonilo. | |
| DE3669515D1 (de) | Makrozyklische antibiotika. | |
| ES2082205T3 (es) | Aparato aplicador de cualquier producto liquido. | |
| US1298840A (en) | Signaling device. | |
| GB245861A (en) | An improved book-rest or holder | |
| BR9815448A (pt) | Derivados de imino-aza-antraciclinona para o tratamento de amiloidose | |
| PH16357A (en) | Indole and indoline derivatives and its pharmaceutical compositions | |
| GB945909A (en) | Morphinone and codeinone derivatives | |
| GR74870B (es) | ||
| Hamp | Locative Singular in"-ei"[Greek] | |
| GB1106100A (en) | Novel 4,5-epoxy-9ª‰,10ª‡-steroids | |
| US1164339A (en) | Curtain-holder. | |
| GB519701A (en) | Improvements in and relating to door checking and door holding device | |
| CO4230085A1 (es) | Derivados de tetrahidropirano | |
| USD75118S (en) | Design fob an observation cage | |
| GB210009A (en) | Improvements in tanks | |
| GB239153A (en) | Improvements in door checks or stops | |
| GB1455997A (en) | M-dioxane-5-methylamine analgesics | |
| GB549430A (en) | Improvements in electrical token apparatus for railways | |
| GB120262A (en) | Holders for Tickets and the like. | |
| GB118367A (en) | Holders for Tickets and the like. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 735047 Country of ref document: ES |